R&D Systems Inc. Tocris Bioscience Boston Biochem

(+)-Bicuculline

Cat. No. 0130

(+)-Bicuculline C20H17NO6 [485-49-4]

Price and Availability

For (+)-Bicuculline pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: [R-(R*,S*)]-6-(5,6,7,8-Tetrahydro-6­-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)furo[3,­4-e]-1,3-benzodioxol-8(6H)-one

Biological Activity

Classical GABAA antagonist. Methoiodide salt (Cat. No. 2503), Methobromide salt (Cat. No. 0109) and Methochloride salt (Cat. No. 0131) also available.

Technical Data

M.Wt:
367.36
Formula:
C20H17NO6
Solubility:
Soluble to 5 mM in ethanol with gentle warming and to 100 mM in DMSO
Purity:
>99 %
Storage:
Desiccate at +4°C
CAS No:
485-49-4

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Select another batch:
Safety Data Sheet: View Safety Data Sheet

References

Merck Index 12 1250.

Curtis et al (1970) GABA, bicuculline and central inhibition. Nature 226 1222. PMID: 4393081.

Olsen et al (1976) Studies on the neuropharmacological activity of bicuculline and related compounds. Brain Res. 102 283. PMID: 1247886.

Piredda et al (1985) Intracerebral site of convulsant action of bicuculline. Life Sci. 36 1295. PMID: 3982215.

Sieghart et al (1989) Multiplicity of GABAA-benzodiazepine receptors. TiPS 10 407. PMID: 2559519.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

Keywords: (+)-Bicuculline, supplier, Potent, GABAA, antagonists, Receptors

Quick Order

Find multiple products by catalog number

divider line

Pain Research Guide

Reserve your free copy

Pain Research Guide

Highlights over 280 products for Pain research. Reserve copy

divider line

GABA Review

GABA Receptors Review

Written by Ian Martin, Norman Bowery & Susan Dunn. Request a copy or view PDF today.

divider line

Therapeutic Strategies in Schizophrenia

Written by J. Lieberman

Schizophrenia Poster

'Schizophrenia - Emerging Targets and Therapeutic Strategies' provides a summary of the targets and pathways representing the most promising strategies to pursue for novel drug development.

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

20% Discount*

Potent, selective LRRK2 inhibitor

Potent LRRK2 inhibitor now available from Tocris Bioscience

Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.

* Terms & conditions